Integration of bulk RNA sequencing to reveal protein arginine methylation regulators have a good prognostic value in...

Area of Science:

• Oncology
• Molecular Biology
• Bioinformatics

Background:

• Protein arginine methylation (PAM) regulators show differential expression and function in lung adenocarcinoma (LUAD).
• The precise role of PAM regulators in LUAD progression and their prognostic significance remain largely unelucidated.
• Understanding PAM regulators is vital for potential diagnostic, prognostic, and therapeutic advancements in LUAD.

Purpose of the Study:

• To investigate the expression patterns and prognostic value of PAM regulators in LUAD.
• To develop a predictive model for LUAD patient outcomes based on PAM regulator expression.
• To explore the relationship between PAM regulator activity, the tumor microenvironment, and immunotherapy response in LUAD.

Main Methods:

• Utilized bioinformatic analysis on 8 datasets comprising 1798 LUAD patients.
• Applied consensus clustering to stratify patients based on 9 PAM regulators.
• Developed a prognostic scoring system (PAM.score) using principal component analysis and identified hub genes.

Main Results:

• Identified two distinct patient clusters and a validated prognostic scoring system (PAM.score).
• A higher PAM.score correlated with poorer prognosis and was validated across multiple cohorts.
• Elevated PAM.score was associated with a lower immune score and an immunosuppressive tumor microenvironment, while lower scores indicated therapeutic benefits.

Conclusions:

• The developed PAM.score model offers a clinically practical tool for personalized therapy selection in LUAD.
• PAM.score may play a significant role in the pathogenesis and progression of LUAD.
• This scoring system aids in stratifying patients for optimal treatment strategies and predicting immunotherapy response.